Mochida Pharmaceutical Co. Ltd
Mochida Pharmaceutical Co., Ltd. manufactures and sells pharmaceuticals and healthcare products in Japan. It offers pharmaceuticals products for the treatment of cardiovascular, obstetrics, gynecology, dermatology, psychiatry, and gastroenterology, including Lialda, Omvoh, and Cortiment for the treatment of ulcerative colitis; Goofice and Movicol for the treatment of chronic constipation; Epadel … Read more
Mochida Pharmaceutical Co. Ltd (MFY) - Total Liabilities
Latest total liabilities as of March 2025: €29.43 Billion EUR
Based on the latest financial reports, Mochida Pharmaceutical Co. Ltd (MFY) has total liabilities worth €29.43 Billion EUR as of March 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Mochida Pharmaceutical Co. Ltd - Total Liabilities Trend (2014–2025)
This chart illustrates how Mochida Pharmaceutical Co. Ltd's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Mochida Pharmaceutical Co. Ltd Competitors by Total Liabilities
The table below lists competitors of Mochida Pharmaceutical Co. Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Xiangyu Medical Co. Ltd. A
SHG:688626
|
China | CN¥1.23 Billion |
|
Anpec Electronics
TWO:6138
|
Taiwan | NT$1.74 Billion |
|
Tangel Publishing
SHE:300148
|
China | CN¥316.83 Million |
|
Bengang Steel Plates Co Ltd
SHE:000761
|
China | CN¥36.45 Billion |
|
New Pacific Metals Corp
NYSE MKT:NEWP
|
USA | $1.39 Million |
|
Beijing Oriental Jicheng Co Ltd
SHE:002819
|
China | CN¥1.33 Billion |
|
Citychamp Dartong Co Ltd
SHG:600067
|
China | CN¥10.26 Billion |
|
Kelt Exploration Ltd
PINK:KELTF
|
USA | $477.39 Million |
Liability Composition Analysis (2014–2025)
This chart breaks down Mochida Pharmaceutical Co. Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 4.81 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.23 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.18 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Mochida Pharmaceutical Co. Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Mochida Pharmaceutical Co. Ltd (2014–2025)
The table below shows the annual total liabilities of Mochida Pharmaceutical Co. Ltd from 2014 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-03-31 | €29.43 Billion | -4.56% |
| 2024-03-31 | €30.84 Billion | -3.81% |
| 2023-03-31 | €32.06 Billion | -7.07% |
| 2022-03-31 | €34.50 Billion | -0.92% |
| 2021-03-31 | €34.82 Billion | -5.44% |
| 2020-03-31 | €36.82 Billion | +8.59% |
| 2019-03-31 | €33.91 Billion | -4.12% |
| 2018-03-31 | €35.37 Billion | -3.11% |
| 2017-03-31 | €36.50 Billion | +11.34% |
| 2016-03-31 | €32.78 Billion | +13.49% |
| 2015-03-31 | €28.89 Billion | -21.89% |
| 2014-03-31 | €36.98 Billion | -- |